Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Red and near-infrared photobiomodulation for burn, hypertrophic, and post-surgical scars: a scoping review of clinical trials

Red and near-infrared PBM appears to be a safe, non-invasive adjunct to standard scar management, particularly for early burn and post-operative scars.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors reviewed seven clinical studies (297 participants) of red and near-infrared photobiomodulation for burn, hypertrophic, and post-surgical scars. They report improvements in scar scores, pigmentation, thickness, pain, and pruritus in several settings, with transient erythema and warmth the most common side effects. The authors state that larger controlled trials are needed.

Participants
297
Studies included
7
Who or what was studied
Patients with burn, hypertrophic, or post-surgical scars, including pediatric and adult participants
Wavelengths
633, 670, 808, 830 nm
Limits stated in the abstract
The abstract describes the evidence as derived from small, heterogeneous studies and calls for larger controlled trials.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Purpose

Scars may lead to pain, pruritus, functional impairment, and cosmetic concern despite standard therapies. Photobiomodulation (PBM) delivered by light-emitting-diode (LED) or low-level laser therapy (LLLT) has emerged as a non-invasive option to modulate scar remodeling. However, available data derives from small, heterogenous studies. This scoping review evaluates whether red and near-infrared PBM improves clinical outcomes in burn, hypertrophic, and post-surgical scars and summarizes treatment parameters used.

Methods

PubMed, Embase, and MEDLINE were searched through October 2025 for randomized or prospective clinical studies in which red (633-670nm) or near-infrared (808-830nm) LED or LLLT was used as monotherapy or where its contribution could be independently assessed. Seven studies (n=297) met inclusion criteria. Data on scar type, wavelength, fluence, regimen, outcomes, and adverse events were extracted.

Results

Red LED improved VSS scores, pigmentation, and thickness in pediatric and adult burn scars, with greater benefits observed in scars < 12 months. In post-surgical scars, red LED reduced induration and improved POSAS scores, with a biphasic dose-response favoring moderate fluence levels. Near-infrared PBM improved color and elasticity in hypertrophic scars and reduced thickness, malleability, pain, and pruritus following hernia repair, thyroidectomy, and blepharoplasty. Across studies, PBM was well tolerated; transient erythema and warmth were most common, with rare blistering at higher fluences.

Conclusion

Red and near-infrared PBM appears to be a safe, non-invasive adjunct to standard scar management, particularly for early burn and post-operative scars. Larger controlled trials are needed to define optimal wavelength, fluence, timing, and treatment parameters across diverse scar phenotypes and skin phototypes. CLINICAL

Trial Registration

Not applicable.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
633-670nm, 808-830nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Near-infrared, Light-emitting diode, Low-level laser therapy, Fluence, Wavelength, Trial registration, Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies